Skip to content
Screener

R&D at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$3.65B+3.9%
Stryker logo
StrykerSYK
$434M+6.6%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
$15.94M+0.1%
Xtant Medical Holdings logo
Xtant Medical HoldingsXTNT
$695K+22.8%
SI-BONE, Inc. logo
SI-BONE, Inc.SIBN
$4.19M-7.5%
Medtronic logo
MedtronicMDT
$671M-1.9%

Other financials

Income statement

See full
Revenue$192.1M+13.6%
Gross profit$136.5M+17.7%
Operating income-$22.6M+49.0%
Net income-$33.9M+34.7%
EPS (diluted)-$0.22+37.1%

Balance sheet

See full
Cash & equivalents$139.9M-8.7%
Total debt$603.1M+3.7%
Total equity-$5.3M+93.8%
Total assets$799.5M+1.8%

Cash flow

See full
Operating cash flow$1.3M+126%
CapEx$12.1M+21.7%
Free cash flow-$10.8M+27.9%

Valuation

See full
Market cap$1.44B-36.6%
Enterprise value$1.9B-29.5%
P/S1.8×-1.5×

Profitability

See full
Gross margin70.2%+1.2pp
Operating margin-7.7%-3.0pp
Net margin-15.9%-4.4pp
FCF margin-12.7%-5.1pp

Returns & leverage

See full
Return on equity-812.1%
Debt / equity48×
Current ratio1.9×-0.9×

Where this comes from

Reported directly by Alphatec Holdings in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The source filing: Alphatec Holdings’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 4:56 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-206683
Line itemThree Months Ended / March 31, 2026Three Months Ended / March 31, 2025
Cost of sales55,63253,184
Gross profit136,476115,996
Operating expenses:
Research and development17,56016,582
Sales, general and administrative137,057127,017
Litigation-related expenses52512,214
Amortization of acquired intangible assets3,9154,103
Restructuring expenses371

Item 1. Financial Statements

FAQ

What is Alphatec Holdings's R&D?
Alphatec Holdings (ATEC) reported R&D of $17.56M in Q1 2026.
How has Alphatec Holdings's R&D changed year-over-year?
Alphatec Holdings's R&D increased by 5.9% year-over-year, from $16.58M to $17.56M.
What is the long-term trend for Alphatec Holdings's R&D?
Over 4 years (2021 to 2025), Alphatec Holdings's R&D has grown at a 24.1% compound annual growth rate (CAGR), from $32.02M to $75.82M.
What does R&D mean?
Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Ask your AI about Alphatec Holdings's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude